Sort
59,101 grants matching “hypertension”
Antenatal Steroids and Cardiometabolic Risk
$474,574James C. Rose · Wake Forest University Health Sciences · P01 · FY2013 · HD
Subclinical Renal Artery Atherosclerosis, Kidney Function and Hypertension
$474,562Matthew A Allison · University Of California, San Diego · R01 · FY2009 · DK
Genetic and Environmental Effects on Clinical Cardiovascular Events in a Large Co
$474,543Redford B Williams · Duke University · P01 · FY2011 · HL
Is mental disorder a preventable cause of age-related disease? The Dunedin Study.
$474,521Terrie Edith Moffitt · Duke University · R01 · FY2012 · AG
Ac-SDKP in the Treatment of Cardiac Dysfunction in Hypertension or Ischemic
$474,519Nour-Eddine Rhaleb · Wayne State University · R01 · FY2021 · HL
Structural Dynamics Of Actomyosin Motility
$474,487Yale E Goldman · University Of Pennsylvania · R01 · FY2009 · GM
Development of Potential Treatment Medications for Drug Abuse
$474,469Bruce E Blough · Research Triangle Institute · R01 · FY2010 · DA
Magnetic Resonance Imaging and Spectroscopy of Rodent Models of Disease
$474,440Richard Spencer · National Institute On Aging · ZIA · FY2021 · AG
Pre Natal Nutrition and Adult Disease
$474,432Columbia University Health Sciences · R01 · FY2002 · HL
Eicosanoid-based Therapy for Diabetes
$474,430John D Imig · Medical College Of Wisconsin · R01 · FY2016 · DK
Eicosanoid-based Therapy for Diabetes
$474,430John D Imig · Medical College Of Wisconsin · R01 · FY2017 · DK
Eicosanoid-based Therapy for Diabetes
$474,430John D Imig · Medical College Of Wisconsin · R01 · FY2019 · DK
Food and Beverage Patterns that Predict Weight Gain Among Adolescents
$474,422Alison E Field · Boston Children'S Hospital · R01 · FY2011 · DK
Real-Time Heteroplasmy Analysis on Microarrays
$474,364Alexander Michael Chagovetz · Salt Lake City Bioscience, Inc. · R44 · FY2009 · GM
INVESTIGATION OF ANG II/AT1 RECEPTORS WITH PET
$474,356Johns Hopkins University · R01 · FY2005 · DK
Novel and Kidney Selective AMPK Activators to Treat Polycystic Kidney Disease
$474,273Ken W Batchelor · Novatarg, Inc. · R44 · FY2015 · DK
PGC-1a and the Energetics of Heart Function and Disease
$474,196Bruce M Spiegelman · Dana-Farber Cancer Inst · R01 · FY2008 · HL
Control of Endothelial Mechanotransduction by the Mitochondrial Ca2+ Uniporter: Implications for Atherosclerosis
$474,184Barbara Rita Alevriadou · Ohio State University · R01 · FY2018 · HL
Testing a Novel Push-Pull Mechanism for Ca2+-Dependent Coupling in BK Channels
$474,110Lawrence B Salkoff · Washington University · R01 · FY2019 · GM
Testing a Novel Push-Pull Mechanism for Ca2+-Dependent Coupling in BK Channels
$474,110Lawrence B Salkoff · Washington University · R01 · FY2018 · GM
Testing a Novel Push-Pull Mechanism for Ca2+-Dependent Coupling in BK Channels
$474,110Lawrence B Salkoff · Washington University · R01 · FY2017 · GM
Impact of Acute Kidney Injury on Kidney Disease Progression
$474,098Talat Alp Ikizler · Vanderbilt University · U01 · FY2012 · DK
Epidemiology of Type 2 Diabetes Mellitus in the Gila River Indian Community
$474,074William C Knowler · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK
Regulation of Renal Function and BP by Thromboxane
$474,063Georgetown University · R37 · FY2004 · DK
Community Engagement Core
$474,054Monica L. Baskin · University Of Alabama At Birmingham · P50 · FY2022 · MD